Product Information
Tilfrinib is a drug that binds to the epidermal growth factor receptor (EGFR) and inhibits its kinase activity. It is an anti-EGFR antibody conjugate or immunoconjugate that is used for the treatment of cancers. The drug contains an antibody that binds to EGFR, which is linked to a cytotoxic agent such as a small molecule, toxin, or radioisotope. Tilfrinib has been shown to be effective in treating cancers with mutations in the EGFR gene.
Chemical properties
Technical inquiry about: 3D-APC51549 Tilfrinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.